PASITHEA THERAPEUTICS CORP. Debt Securities, Available-for-sale, Current
PASITHEA THERAPEUTICS CORP. (KTTA) had Debt Securities, Available-for-sale, Current of $95.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2023-11-13
- 2023-09-30: Debt Securities, Available-for-sale, Current $95.00K.
- 2023-06-30: Debt Securities, Available-for-sale, Current $122.50K.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2023-09-30 | $95.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $122.50K 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |